Article
Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.
British journal of pharmacology - 1 May 2015
Farinha A, Lavreysen H, Peeters L, Russo B, Masure S, Trabanco A A, Cid J, Tresadern G
Abstract excerpt
BACKGROUND AND PURPOSE: The activation of the metabotropic glutamate receptor 2 (mGlu2 ) reduces glutamatergic transmission in brain regions where excess excitatory signalling is implicated in disorders such as anxiety and schizophrenia. Positive allosteric modulators (PAMs) can provide a fine-tuned potentiation of these receptors' function and are being investigated as a novel therapeutic approach. An extensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
